New therapeutic strategies for hepatitis C.
Di Bisceglie
Adrian M
AM
Saint Louis University, St. Louis MO 63110, USA. disbiscam@slu.edu
McHutchison
John
J
Rice
Charles M
CM
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D018929:Cell Culture Techniques; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D016174:Hepacivirus / Q000201:enzymology; D006526:Hepatitis C / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D008107:Liver Diseases / Q000517:prevention & control; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D012254:Ribavirin; D007372:Interferons; D007168:IMP Dehydrogenase